AMGEN INC·4

Mar 5, 8:19 PM ET

Bradway Robert A 4

4 · AMGEN INC · Filed Mar 5, 2026

Insider Transaction Report

Form 4
Period: 2026-03-03
Bradway Robert A
DirectorChairman, CEO and President
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-03+42,657457,146 total
Holdings
  • Common Stock

    (indirect: By GRAT)
    90,000
  • Common Stock

    (indirect: By Spousal GRAT)
    90,000
Footnotes (1)
  • [F1]These shares include 2,414 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Signature
/s/ Robert A. Bradway|2026-03-05

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT